Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Bayer launches Kinzalmono and Kinzalkomb

March 27, 2003

Peptides described with the ability to bind to atherosclerotic lesions

March 27, 2003

Genzyme Biosurgery and Excigen collaborate on gene therapy for cardiac arrhythmias

March 27, 2003

Antithrombotic and antiinflammatory effects described for drotrecogin alfa (activated) in sepsis

March 26, 2003

Alphav integrin antagonists discovered by Merck KGaA researchers

March 26, 2003

Actelion scientists present novel series of endothelin antagonists

March 25, 2003

Aderis receives DTI-0009 development milestone payment

March 21, 2003

Selective NCX inhibitor reduces myocardial ischemic injury in rabbits

March 21, 2003

HOPE data on the costs of ramipril therapy in cardiovascular diseases

March 20, 2003

Further analysis of DIAMOND study data reported

March 19, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...